Indexes of β-cell function from the oral glucose tolerance test can modestly predict pancreatic β-cell area in Korean

Diabetes Research and Clinical Practice

Volumn 93, Issue 2, 2011, Pages 220-227

  Kim, Soo Kyoung ^a   Kim, Jae Hyeon ^a   Park, Ji Young ^a   No, Hee Sung ^b   Jang, Kee Taek ^a   Heo, Jin Seok ^a   Choi, Seong Ho ^a   Choi, Dong Wook ^a   Kim, Kwang Won ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Cell area; Cell function; Oral glucose tolerance test

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; KOREA; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL FUNCTION; PANCREAS RESECTION; PREDICTION;

AGED; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; KOREA; MALE; MIDDLE AGED; PANCREAS; PREDIABETIC STATE;

EID: 80051564825     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.04.020     Document Type: Article

References (28)

1. Ferrannini E., Gastaldelli A., Miyazaki Y., Matsuda M., Mari A., DeFronzo R.A. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005, 90:493-500.
2. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. beta-Cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
3. Ritzel R.A., Butler A.E., Rizza R.A., Veldhuis J.D., Butler P.C. Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 2006, 29:717-718.
4. Yoon K.H., Ko S.H., Cho J.H., Lee J.M., Ahn Y.B., Song K.H., et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003, 88:2300-2308.
5. Kahn S.E., Halban P.A. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 1997, 46:1725-1732.
6. Rahier J., Guiot Y., Goebbels R.M., Sempoux C., Henquin J.C. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008, 10:32-42.
7. Clark A., Jones L.C., de Koning E., Hansen B.C., Matthews D.R. Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?. Diabetes 2001, 50:S169-S171.
8. Seaquist E.R., Robertson R.P. Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 1992, 89:1761-1766.
9. McCulloch D.K., Koerker D.J., Kahn S.E., Bonner-Weir S., Palmer J.P. Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons. Diabetes 1991, 40:673-679.
10. Teuscher A.U., Kendall D.M., Smets Y.F., Leone J.P., Sutherland D.E., Robertson R.P. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998, 47:324-330.
11. Meier J.J., Menge B.A., Breuer T.G., Muller C.A., Tannapfel A., Uhl W., et al. Functional assessment of pancreatic beta-cell area in humans. Diabetes 2009, 58:1595-1603.
12. Haeckel R., Raber R., Wosniok W. Comparability of indices for insulin resistance and insulin secretion determined during oral glucose tolerance tests. Clin Chem Lab Med 2006, 44:817-823.
13. Sakuraba H., Mizukami H., Yagihashi N., Wada R., Hanyu C., Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002, 45:85-96.
14. Kim D.J., Lee M.S., Kim K.W., Lee M.K. Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus. Metabolism 2001, 50:590-593.
15. Park J.Y., Lee K.U., Kim C.H., Kim H.K., Hong S.K., Park K.S., et al. Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1997, 35:49-56.
16. Phillips D.I., Clark P.M., Hales C.N., Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994, 11:286-292.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
18. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003, 46:3-19.
19. Gutt M., Davis C.L., Spitzer S.B., Llabre M.M., Kumar M., Czarnecki E.M., et al. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 2000, 47:177-184.
20. Tobin B.W., Lewis J.T., Chen D.Z., Finegood D.T. Insulin secretory function in relation to transplanted islet mass in STZ-induced diabetic rats. Diabetes 1993, 42(1):98-105.
21. Ryan E.A., Lakey J.R., Paty B.W., Imes S., Korbutt G.S., Kneteman N.M., et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002, 51:2148-2157.
22. Slezak L.A., Andersen D.K. Pancreatic resection: effects on glucose metabolism. World J Surg 2001, 25:452-460.
23. Schrader H., Menge B.A., Zeidler C., Ritter P.R., Tannapfel A., Uhl W., et al. Determinants of glucose control in patients with chronic pancreatitis. Diabetologia 2010, 53:1062-1069.
24. Deng S., Vatamaniuk M., Huang X., Doliba N., Lian M.M., Frank A., et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004, 53:624-632.
25. Pipeleers D.G. Heterogeneity in pancreatic beta-cell population. Diabetes 1992, 41:777-781.
26. Asghar Z., Yau D., Chan F., Leroith D., Chan C.B., Wheeler M.B. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes. Diabetologia 2006, 49:90-99.
27. Gullo L., Pezzilli R., Morselli-Labate A.M. Diabetes and the risk of pancreatic cancer. N Engl J Med 1994, 331:81-84.
28. Katsumichi I., Pour P.M. Diabetes mellitus in pancreatic cancer: is it a causal relationship?. Am J Surg 2007, 194:S71-S75.